Evogene (EVGN) — Working Capital to Net Assets Ratio
Evogene (EVGN) has a Working Capital to Net Assets ratio of 92.7% as of September 2025. Working capital of ILA15.99 Million (current assets of ILA20.06 Million minus current liabilities of ILA4.08 Million) is measured against net assets of ILA17.25 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See EVGN net asset quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Evogene Working Capital to Net Assets (2012–2024)
This chart shows how Evogene's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2012 to 2024. As of September 2025, the ratio stands at 92.7%, reflecting working capital of ILA15.99 Million against net assets of ILA17.25 Million ILA. Check Evogene tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Evogene (2012–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Evogene from 2012 to 2024, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Evogene (EVGN) total market value.
| Year | WC/NA Ratio | Working Capital (ILA) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 19.5% | ILA2.89 Million | ILA14.84 Million | ILA21.59 Million | ILA18.70 Million | ▼ -76.5 pp |
| 2023 | 96.0% | ILA27.52 Million | ILA28.68 Million | ILA34.47 Million | ILA6.94 Million | ▲ +3.6 pp |
| 2022 | 92.3% | ILA32.13 Million | ILA34.79 Million | ILA37.75 Million | ILA5.62 Million | ▲ +13.5 pp |
| 2021 | 78.9% | ILA50.01 Million | ILA63.42 Million | ILA56.89 Million | ILA6.88 Million | ▲ +4.8 pp |
| 2020 | 74.1% | ILA42.15 Million | ILA56.88 Million | ILA51.82 Million | ILA9.68 Million | ▲ +2.2 pp |
| 2019 | 71.9% | ILA43.30 Million | ILA60.22 Million | ILA49.03 Million | ILA5.73 Million | ▼ -27.6 pp |
| 2018 | 99.5% | ILA50.06 Million | ILA50.31 Million | ILA55.49 Million | ILA5.43 Million | ▲ +1.3 pp |
| 2017 | 98.2% | ILA68.13 Million | ILA69.38 Million | ILA72.79 Million | ILA4.66 Million | ▲ +1.7 pp |
| 2016 | 96.5% | ILA84.27 Million | ILA87.29 Million | ILA89.49 Million | ILA5.22 Million | ▲ +1.4 pp |
| 2015 | 95.2% | ILA98.74 Million | ILA103.75 Million | ILA104.38 Million | ILA5.64 Million | ▲ +0.0 pp |
| 2014 | 95.1% | ILA110.45 Million | ILA116.08 Million | ILA118.37 Million | ILA7.92 Million | ▼ -1.8 pp |
| 2013 | 97.0% | ILA120.98 Million | ILA124.75 Million | ILA129.55 Million | ILA8.57 Million | ▼ -2.1 pp |
| 2012 | 99.1% | ILA47.82 Million | ILA48.26 Million | ILA57.32 Million | ILA9.50 Million | — |